BA
MRK icon

Bristlecone Advisors’s Merck MRK Stock Holding History

Bristlecone Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.07M Sell
12,701
-1,370
-10% -$113K 0.09% 123
2025
Q2 		$1.11M Sell
14,071
-18,975
-57% -$1.51M 0.09% 123
2025
Q1 		$2.97M Buy
33,046
+8,217
+33% +$767K 0.24% 84
2024
Q4 		$2.47M Buy
24,829
+2,519
+11% +$260K 0.19% 95
2024
Q3 		$2.53M Buy
22,310
+1,290
+6% +$153K 0.2% 94
2024
Q2 		$2.6M Buy
21,020
+334
+2% +$43K 0.22% 90
2024
Q1 		$2.73M Buy
20,686
+568
+3% +$70K 0.24% 87
2023
Q4 		$2.19M Sell
20,118
-393
-2% -$40.8K 0.22% 94
2023
Q3 		$2.11M Buy
20,511
+1,284
+7% +$138K 0.24% 92
2023
Q2 		$2.22M Buy
19,227
+174
+0.9% +$19.8K 0.22% 90
2023
Q1 		$2.03M Buy
19,053
+529
+3% +$57.1K 0.22% 94
2022
Q4 		$2.06M Buy
18,524
+2,189
+13% +$224K 0.25% 84
2022
Q3 		$1.41M Buy
16,335
+9,817
+151% +$876K 0.18% 100
2022
Q2 		$594K Buy
6,518
+1,876
+40% +$166K 0.07% 155
2022
Q1 		$381K Buy
+4,642
New +$366K 0.05% 183
2020
Q1 		– Sell
-7,206
Closed -$625K – 186
2019
Q4 		$625K Buy
+7,206
New +$592K 0.13% 121
2019
Q3 		– Sell
-7,206
Closed -$577K – 165
2019
Q2 		$577K Buy
+7,206
New +$552K 0.14% 112
2017
Q4 		– Sell
-2,645
Closed -$162K – 230
2017
Q3 		$162K Buy
+2,645
New +$160K 0.05% 148
2017
Q1 		– Sell
-4,396
Closed -$247K – 155
2016
Q4 		$247K Sell
4,396
-39
-0.9% -$2.28K 0.09% 132
2016
Q3 		$264K Buy
4,435
+230
+5% +$13.4K 0.1% 135
2016
Q2 		$231K Sell
4,205
-534
-11% -$28.4K 0.09% 128
2016
Q1 		$239K Buy
4,739
+445
+10% +$21.8K 0.09% 147
2015
Q4 		$216K Buy
+4,294
New +$216K 0.09% 163

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bristlecone Advisors's MRK Position: Q3 2025 in Review

Bristlecone Advisors reduced its Merck (MRK) stake by 9.7% in Q3 2025, selling an estimated $113K and leaving 12,701 shares worth $1.07M. The position accounts for 0.09% of the portfolio, ranked #123.

Bristlecone Advisors first reported a position in MRK in Q4 2015 and has held it in 23 quarters since. The position peaked at $2.97M in Q1 2025. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Bristlecone Advisors held 12,701 shares of Merck worth $1.07M as of Q3 2025.
  • Bristlecone Advisors sold 1,370 Merck shares in Q3 2025, an estimated $113K.
  • Merck made up 0.09% of Bristlecone Advisors's portfolio in Q3 2025, its #123 holding.
  • Bristlecone Advisors first reported a position in Merck in Q4 2015 and has held it in 23 quarters since.
  • Bristlecone Advisors's Merck position peaked at $2.97M in Q1 2025.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Bristlecone Advisors's 13F filing for Q3 2025, filed 24 Oct 2025.